Atyr Pharma Inc (ATYR) Stock Price, Quote & News

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 731 8389

Fax: 858 731 8394

Website: atyrpharma.com

Address:

10240 Sorrento Valley Road, Suite 300, San Diego, United States

Notwallstreetjesus Jul. 14 at 12:39 PM

$ATYR soon there will be an announcement that some will benefit from, and some will FOMO. Which will you be?

1 · Reply

stefano62 Jul. 13 at 7:48 PM

$ATYR today Is a deeply Red day for all small biotech, but forevsure we are also pyong the missed PR announcing the new IND submitted...m

0 · Reply

bigron8671 Jul. 13 at 3:14 PM

$ATYR almost 7 million shares bought back since 5-15 as they play their game to hold it down while buying.

1 · Reply

bigron8671 Jul. 13 at 1:49 PM

$ATYR SI down to 15%

0 · Reply

Deng42 Jul. 12 at 11:14 PM

$AREB $ATYR $ELAB $AAL

0 · Reply

AtariLynx Jul. 10 at 1:48 PM

$ATYR back under .50?!

0 · Reply

Jmdouk2 Jul. 10 at 1:47 PM

$ATYR wow they just going to run this back down again smh

0 · Reply

stefano62 Jul. 9 at 5:56 PM

$ATYR why this High volatility in the last 3-4 days?

0 · Reply

Stockinvestigator420 Jul. 9 at 5:41 PM

$ATYR the rule is…. Whatever you think is gonna happen, it doesn’t. Welcome to the stock market. Also it’s a micro under 1$ so it’s never just straight up. I bet a month from now she’s way up tho.

2 · Reply

trader2sde Jul. 9 at 4:43 PM

$ATYR MS was right all along

0 · Reply

Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026

LIFE

Jun 25, 2026, 3:30 PM EDT - 19 days ago

aTyr Pharma Transcript: Life Sciences Virtual Investor Forum

Jun 4, 2026, 3:45 PM EDT - 5 weeks ago

aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026

May 26, 2026, 3:08 PM EDT - 7 weeks ago

Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now.

LIFE PTRN

May 21, 2026, 9:07 AM EDT - 7 weeks ago

Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential

LIFE

2026-05-20T13:00:12.000Z - 7 weeks ago

aTyr Pharma upgraded to Buy from Hold at Freedom Broker

May 15, 2026, 4:30 PM EDT - 2 months ago

Ethos to Present at Upcoming Investor Conferences

LIFE

2026-05-15T15:42:31.000Z - 2 months ago

aTyr Pharma reports Q1 EPS (11c), consensus (15c)

May 15, 2026, 8:00 AM EDT - 2 months ago

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

May 15, 2026, 7:00 AM EDT - 2 months ago

aTyr Pharma Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

aTyr Pharma Earnings release: Q1 2026

May 13, 2026, 4:35 PM EDT - 2 months ago

Ethos Announces Early Lock-Up Release

LIFE

May 13, 2026, 4:01 PM EDT - 2 months ago

aTyr Pharma to Participate in Upcoming Investor Conferences

2026-05-11T23:05:03.000Z - 2 months ago

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

May 11, 2026, 4:30 PM EDT - 2 months ago

aTyr Pharma Transcript: Study update

May 11, 2026, 4:30 PM EDT - 2 months ago

aTyr Pharma Press release: Study update

May 11, 2026, 4:30 PM EDT - 2 months ago

aTyr Pharma Slides: Study update

May 11, 2026, 4:01 PM EDT - 2 months ago

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

May 6, 2026, 4:05 PM EDT - 2 months ago

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

LIFE

May 5, 2026, 9:07 AM EDT - 2 months ago

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

LIFE

Apr 23, 2026, 9:07 AM EDT - 2 months ago

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

LIFE

Apr 2, 2026, 4:05 PM EDT - 3 months ago

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

LIFE

Mar 26, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Proxy statement: Proxy filing

Mar 24, 2026, 4:05 PM EDT - 4 months ago

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

LIFE

Mar 12, 2026, 8:00 AM EDT - 4 months ago

aTyr Pharma Proxy statement: Proxy Filing

Mar 11, 2026, 8:00 AM EDT - 4 months ago

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

2026-03-05T21:05:56.000Z - 4 months ago

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

Mar 5, 2026, 4:01 PM EST - 4 months ago

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

Mar 5, 2026, 3:00 PM EST - 4 months ago

aTyr Pharma Annual report: Q4 2025

Mar 5, 2026, 3:00 PM EST - 4 months ago

aTyr Pharma Earnings release: Q4 2025

Feb 26, 2026, 4:06 PM EST - 4 months ago

Ethos to Participate in The Citizens Technology Conference

LIFE

Feb 25, 2026, 4:05 PM EST - 4 months ago

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

LIFE

Feb 20, 2026, 4:01 PM EST - 5 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 18, 2026, 8:00 AM EST - 5 months ago

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Feb 5, 2026, 4:05 PM EST - 5 months ago

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

LIFE

Feb 3, 2026, 2:46 PM EST - 5 months ago

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

FPS LFTO YSS

2026-02-03T13:10:35.000Z - 5 months ago

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

Feb 3, 2026, 8:00 AM EST - 5 months ago

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Jan 29, 2026, 12:30 PM EST - 5 months ago

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Jan 28, 2026, 10:38 PM EST - 5 months ago

Ethos Announces Pricing of Initial Public Offering

Jan 28, 2026, 9:05 PM EST - 5 months ago

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Jan 7, 2026, 8:01 AM EST - 6 months ago

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Dec 18, 2025, 8:01 AM EST - 7 months ago

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Dec 15, 2025, 2:45 PM EST - 7 months ago

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

Dec 8, 2025, 3:25 AM EST - 7 months ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Dec 2, 2025, 1:00 PM EST - 8 months ago

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

2025-11-25T15:09:57.000Z - 8 months ago

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

2025-11-06T21:26:32.000Z - 8 months ago

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

Nov 6, 2025, 4:00 PM EST - 8 months ago

aTyr Pharma Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 8 months ago

aTyr Pharma Quarterly report: Q3 2025

2025-09-30T10:20:48.000Z - 10 months ago

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

2025-09-29T20:40:08.000Z - 10 months ago

Piper Sandler healthcare analysts hold an analyst/industry conference call

2025-09-15T20:30:25.000Z - 10 months ago

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

2025-09-15T18:00:09.000Z - 10 months ago

Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure

Notwallstreetjesus Jul. 14 at 12:39 PM

$ATYR soon there will be an announcement that some will benefit from, and some will FOMO. Which will you be?

1 · Reply

stefano62 Jul. 13 at 7:48 PM

$ATYR today Is a deeply Red day for all small biotech, but forevsure we are also pyong the missed PR announcing the new IND submitted...m

0 · Reply

bigron8671 Jul. 13 at 3:14 PM

$ATYR almost 7 million shares bought back since 5-15 as they play their game to hold it down while buying.

1 · Reply

bigron8671 Jul. 13 at 1:49 PM

$ATYR SI down to 15%

0 · Reply

Deng42 Jul. 12 at 11:14 PM

$AREB $ATYR $ELAB $AAL

0 · Reply

AtariLynx Jul. 10 at 1:48 PM

$ATYR back under .50?!

0 · Reply

Jmdouk2 Jul. 10 at 1:47 PM

$ATYR wow they just going to run this back down again smh

0 · Reply

stefano62 Jul. 9 at 5:56 PM

$ATYR why this High volatility in the last 3-4 days?

0 · Reply

Stockinvestigator420 Jul. 9 at 5:41 PM

2 · Reply

trader2sde Jul. 9 at 4:43 PM

$ATYR MS was right all along

0 · Reply

trader2sde Jul. 9 at 4:42 PM

$ATYR

1 · Reply

AnUnwiseInvestor Jul. 8 at 4:58 PM

$ATYR I am not going to buy in specifically because it will cause this to drop bad like on OSTX when I bought at 2.20. See you friends at $1 land.

0 · Reply

ajmrtxl Jul. 8 at 4:09 PM

$ATYR 's latest squeeze play

1 · Reply

Wallace911 Jul. 8 at 2:04 PM

$ATYR good news yesssss let’s go darling

0 · Reply

enzomassimi Jul. 8 at 2:04 PM

$ATYR GO GO GO

0 · Reply

doangroup789 Jul. 8 at 1:59 PM

$ATYR ALL IN

0 · Reply

Dodan Jul. 8 at 1:51 PM

$ATYR low volyme, let's see where this goes.

0 · Reply

Stwanker Jul. 8 at 12:24 PM

$ATYR federated Hermes just dropped a silent 13G that they own 8% share of this company.. institutional confidence 🚀 NFA

0 · Reply

MilkingAlgosEveryMonday Jul. 8 at 9:38 AM

$OTLK time to add more , $VG $ATYR its our money!

0 · Reply

Danielsia Jul. 8 at 7:58 AM

$ATYR

0 · Reply

Jmdouk2 Jul. 7 at 9:00 PM

$ATYR this was looking so good… 🥲

0 · Reply

heyupikachu1821 Jul. 7 at 8:02 PM

$ATYR today’s price action was the exact same thing that happened the day before Phase 3 results were revealed. Strong move up all day, dumped everything and more in the last few minutes. if we get some sort of bad news, I hope this company gets sued out of existence

0 · Reply

Market Cap	49.43M
Revenue (ttm)	190,000.00
Net Income (ttm)	-74.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-39,010.53%
Debt to Equity Ratio	0.00

Volume	938,100
Avg Vol	3,106,824
Day's Range	N/A - N/A
Shares Out	98.05M
Stochastic %K	7%
Beta	0.52
Analysts	Sell
Price Target	$2.75